[Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by glypentide and other oral antidiabetic agents (author's transl)].
D000284:Administration, Oral; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D000242:Cyclic AMP; D006321:Heart / Q000187:drug effects; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D009206:Myocardium / Q000201:enzymology*; D010726:Phosphodiesterase Inhibitors; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000494:pharmacology*
D007004:Hypoglycemic Agents; D010726:Phosphodiesterase Inhibitors; D013453:Sulfonylurea Compounds; D000242:Cyclic AMP
Inhibición de la fosfodiesterasa del AMPc por la glipentida y otros antidiabéticos orales